Consistently, other studies also suggest that a low BATF2 level is a risk factor for the poor prognosis in non-small cell lung cancer; BATF2 deletion promotes the EMT process, leading to LUAD cell invasion and metastasis [15]. The gene discussed is BATF2; the disease is non-small cell lung carcinoma.